Miranda van Eck is professor in Cardiovascular and Metabolic Therapeutics, deputy Director of the Leiden Academic Centre for Drug Research (LACDR), and director of the master programme Bio-Pharmaceutical Sciences at Leiden University, the Netherlands.
Prof. Van Eck received her education at Leiden University where she obtained her PhD in 1999. She is an expert in HDL metabolism, macrophage biology, and the identification of novel therapeutic targets for intervention in cardiovascular and metabolic disease.
Van Eck has over 150 publications in major international peer-reviewed scientific journals in the atherosclerosis field. Apart from attracting many citations, her work has led to a great number of invitations for key lectures at international meetings, including at EAS congresses and several successful grant applications, including highly competitive Innovational Research grants from the Netherlands Organization for Scientific Research. Van Eck has received several prestigious awards, including the Galenus Research Prize which recognizes innovative pharmaceutical research in the Netherlands and twice an award from the International HDL Research Award Program for outstanding investigators in the field of HDL biology. Furthermore, since 2008, Van Eck is recognized as an Established Investigator by the Netherlands Heart Foundation. She is associate editor of the journals “Atherosclerosis” and “Atherosclerosis Plus”. As founding board member of the women’s network RISE at Leiden University, Prof. Van Eck also strives for gender equality in science and aims to be a role model for young female cardiovascular scientists at EAS.